SECTOR ANALYSIS

Oncology Diagnostics Biotech Companies

Grades, scores, and FDA catalyst signals for Oncology Diagnostics stocks tracked by BiotechSigns

← Full ScreenerFDA CalendarAll Sectors
Companies
21
Avg Score
54
Top Grade
B
Oncology Diagnostics Companies21 tracked
TickerCompanyScoreGradeSectorSignals
NUVBNuvation Bio69BOncology
TXG10x Genomics, Inc.68BDiagnostics
LBPHLongboard Pharmaceuticals66BOncology
SNDXSyndax Pharmaceuticals63COncology
KURAKura Oncology, Inc.60COncology
INCYIncyte Corporation60COncology
HOOKHOOKIPA Pharma59COncology
CELCCelcuity Inc58COncology
HCMHUTCHMED China58COncology
NUVLNuvalent Inc57COncology
EXELExelixis Inc55COncology
KRONKronos Bio53COncology
BOLDBold Therapeutics52COncology
CRVSCorvus Pharmaceuticals49DOncology
TOIThe Oncology Institute, Inc.48DOncology
DGXQuest Diagnostics Incorporated45DDiagnostics
BGNEBeiGene Ltd44DOncology
RAPTRAPT Therapeutics44DOncology
EXASExact Sciences43DDiagnostics
IMGNImmunoGen Inc42DOncology
GHGuardant Health41DOncology Diagnostics
Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSigns grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.